Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
30
SINT Quote, Financials, Valuation and Earnings
Last price:
$3.74
Seasonality move
:
-21.85%
Day range:
$3.69 - $3.89
52-week range:
$2.01 - $105.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.01x
P/B ratio:
0.89x
Volume:
26.9K
Avg. volume:
2.2M
1-year change:
-96.06%
Market cap:
$5M
Revenue:
$1.2M
EPS (TTM):
-$141.20
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SINT
SINTX Technologies
|
$700K | -$5.29 | 20.07% | -96.58% | -- |
|
CVRX
CVRx
|
$13.2M | -$0.47 | 34.46% | -11.77% | -- |
|
NMTC
NeuroOne Medical Technologies
|
-- | -- | 157.41% | -57.14% | -- |
|
NTRB
Nutriband
|
-- | -- | -- | -- | -- |
|
NVNO
enVVeno Medical
|
-- | -$0.33 | -- | -26.67% | -- |
|
XAIR
Beyond Air
|
$1M | -- | 138.36% | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SINT
SINTX Technologies
|
$3.70 | -- | $5M | -- | $0.00 | 0% | 1.01x |
|
CVRX
CVRx
|
$12.90 | -- | $313M | -- | $0.00 | 0% | 5.90x |
|
NMTC
NeuroOne Medical Technologies
|
$0.77 | -- | $23.7M | -- | $0.00 | 0% | 5.97x |
|
NTRB
Nutriband
|
$3.89 | -- | $43.2M | -- | $0.00 | 0% | 19.07x |
|
NVNO
enVVeno Medical
|
$2.82 | -- | $49.5M | -- | $0.00 | 0% | 240.51x |
|
XAIR
Beyond Air
|
$0.42 | -- | $30.4M | -- | $0.00 | 0% | 7.31x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SINT
SINTX Technologies
|
2.35% | 0.698 | 3.06% | 2.48x |
|
CVRX
CVRx
|
43.02% | 0.327 | 23.08% | 9.97x |
|
NMTC
NeuroOne Medical Technologies
|
-- | -1.235 | -- | 0.74x |
|
NTRB
Nutriband
|
1.68% | 2.279 | 0.28% | 4.65x |
|
NVNO
enVVeno Medical
|
-- | 2.437 | -- | -- |
|
XAIR
Beyond Air
|
28.48% | 1.673 | 38.38% | 4.46x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SINT
SINTX Technologies
|
$157K | -$2M | -130.78% | -132.95% | -1697.55% | -$2.6M |
|
CVRX
CVRx
|
$11.1M | -$13M | -58.86% | -84.64% | -90.44% | -$10.4M |
|
NMTC
NeuroOne Medical Technologies
|
$141.1K | -$2.8M | -335.54% | -335.54% | -1108.64% | -$2.7M |
|
NTRB
Nutriband
|
$191K | -$1.4M | -65.19% | -69.58% | -210.38% | -$1.1M |
|
NVNO
enVVeno Medical
|
-- | -$6.2M | -- | -- | -- | -$4.3M |
|
XAIR
Beyond Air
|
-$1.1M | -$12.8M | -140.46% | -219.34% | -1641.86% | -$14.5M |
SINTX Technologies vs. Competitors
-
Which has Higher Returns SINT or CVRX?
CVRx has a net margin of -1700% compared to SINTX Technologies's net margin of -97.95%. SINTX Technologies's return on equity of -132.95% beat CVRx's return on equity of -84.64%.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies42.78% -$6.96 $5.7M CVRXCVRx83.19% -$0.57 $114.4M -
What do Analysts Say About SINT or CVRX?
SINTX Technologies has a consensus price target of --, signalling upside risk potential of 1791.89%. On the other hand CVRx has an analysts' consensus of -- which suggests that it could grow by 40.83%. Given that SINTX Technologies has higher upside potential than CVRx, analysts believe SINTX Technologies is more attractive than CVRx.
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies0 0 0 CVRXCVRx0 0 0 -
Is SINT or CVRX More Risky?
SINTX Technologies has a beta of 1.497, which suggesting that the stock is 49.673% more volatile than S&P 500. In comparison CVRx has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SINT or CVRX?
SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. CVRx pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or CVRX?
SINTX Technologies quarterly revenues are $367K, which are smaller than CVRx quarterly revenues of $13.4M. SINTX Technologies's net income of -$6.2M is higher than CVRx's net income of -$13.1M. Notably, SINTX Technologies's price-to-earnings ratio is -- while CVRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 1.01x versus 5.90x for CVRx. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies1.01x -- $367K -$6.2M CVRXCVRx5.90x -- $13.4M -$13.1M
-
Which has Higher Returns SINT or NMTC?
NeuroOne Medical Technologies has a net margin of -1700% compared to SINTX Technologies's net margin of -1230.55%. SINTX Technologies's return on equity of -132.95% beat NeuroOne Medical Technologies's return on equity of -335.54%.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies42.78% -$6.96 $5.7M NMTCNeuroOne Medical Technologies51.81% -$0.11 $822K -
What do Analysts Say About SINT or NMTC?
SINTX Technologies has a consensus price target of --, signalling upside risk potential of 1791.89%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of -- which suggests that it could grow by 159.81%. Given that SINTX Technologies has higher upside potential than NeuroOne Medical Technologies, analysts believe SINTX Technologies is more attractive than NeuroOne Medical Technologies.
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies0 0 0 NMTCNeuroOne Medical Technologies0 0 0 -
Is SINT or NMTC More Risky?
SINTX Technologies has a beta of 1.497, which suggesting that the stock is 49.673% more volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.688, suggesting its less volatile than the S&P 500 by 31.224%.
-
Which is a Better Dividend Stock SINT or NMTC?
SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or NMTC?
SINTX Technologies quarterly revenues are $367K, which are larger than NeuroOne Medical Technologies quarterly revenues of $272.3K. SINTX Technologies's net income of -$6.2M is lower than NeuroOne Medical Technologies's net income of -$3.4M. Notably, SINTX Technologies's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 1.01x versus 5.97x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies1.01x -- $367K -$6.2M NMTCNeuroOne Medical Technologies5.97x -- $272.3K -$3.4M
-
Which has Higher Returns SINT or NTRB?
Nutriband has a net margin of -1700% compared to SINTX Technologies's net margin of -211%. SINTX Technologies's return on equity of -132.95% beat Nutriband's return on equity of -69.58%.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies42.78% -$6.96 $5.7M NTRBNutriband29.58% -$0.12 $11.4M -
What do Analysts Say About SINT or NTRB?
SINTX Technologies has a consensus price target of --, signalling upside risk potential of 1791.89%. On the other hand Nutriband has an analysts' consensus of -- which suggests that it could grow by 362.61%. Given that SINTX Technologies has higher upside potential than Nutriband, analysts believe SINTX Technologies is more attractive than Nutriband.
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies0 0 0 NTRBNutriband0 0 0 -
Is SINT or NTRB More Risky?
SINTX Technologies has a beta of 1.497, which suggesting that the stock is 49.673% more volatile than S&P 500. In comparison Nutriband has a beta of 0.358, suggesting its less volatile than the S&P 500 by 64.193%.
-
Which is a Better Dividend Stock SINT or NTRB?
SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or NTRB?
SINTX Technologies quarterly revenues are $367K, which are smaller than Nutriband quarterly revenues of $645.8K. SINTX Technologies's net income of -$6.2M is lower than Nutriband's net income of -$1.4M. Notably, SINTX Technologies's price-to-earnings ratio is -- while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 1.01x versus 19.07x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies1.01x -- $367K -$6.2M NTRBNutriband19.07x -- $645.8K -$1.4M
-
Which has Higher Returns SINT or NVNO?
enVVeno Medical has a net margin of -1700% compared to SINTX Technologies's net margin of --. SINTX Technologies's return on equity of -132.95% beat enVVeno Medical's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies42.78% -$6.96 $5.7M NVNOenVVeno Medical-- -$0.35 -- -
What do Analysts Say About SINT or NVNO?
SINTX Technologies has a consensus price target of --, signalling upside risk potential of 1791.89%. On the other hand enVVeno Medical has an analysts' consensus of -- which suggests that it could grow by 538.3%. Given that SINTX Technologies has higher upside potential than enVVeno Medical, analysts believe SINTX Technologies is more attractive than enVVeno Medical.
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies0 0 0 NVNOenVVeno Medical0 0 0 -
Is SINT or NVNO More Risky?
SINTX Technologies has a beta of 1.497, which suggesting that the stock is 49.673% more volatile than S&P 500. In comparison enVVeno Medical has a beta of 1.219, suggesting its more volatile than the S&P 500 by 21.904%.
-
Which is a Better Dividend Stock SINT or NVNO?
SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or NVNO?
SINTX Technologies quarterly revenues are $367K, which are larger than enVVeno Medical quarterly revenues of --. SINTX Technologies's net income of -$6.2M is lower than enVVeno Medical's net income of -$5.6M. Notably, SINTX Technologies's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 1.01x versus 240.51x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies1.01x -- $367K -$6.2M NVNOenVVeno Medical240.51x -- -- -$5.6M
-
Which has Higher Returns SINT or XAIR?
Beyond Air has a net margin of -1700% compared to SINTX Technologies's net margin of -1673.94%. SINTX Technologies's return on equity of -132.95% beat Beyond Air's return on equity of -219.34%.
Company Gross Margin Earnings Per Share Invested Capital SINTSINTX Technologies42.78% -$6.96 $5.7M XAIRBeyond Air-135.84% -$0.28 $40.5M -
What do Analysts Say About SINT or XAIR?
SINTX Technologies has a consensus price target of --, signalling upside risk potential of 1791.89%. On the other hand Beyond Air has an analysts' consensus of -- which suggests that it could grow by 493.4%. Given that SINTX Technologies has higher upside potential than Beyond Air, analysts believe SINTX Technologies is more attractive than Beyond Air.
Company Buy Ratings Hold Ratings Sell Ratings SINTSINTX Technologies0 0 0 XAIRBeyond Air0 0 0 -
Is SINT or XAIR More Risky?
SINTX Technologies has a beta of 1.497, which suggesting that the stock is 49.673% more volatile than S&P 500. In comparison Beyond Air has a beta of -0.225, suggesting its less volatile than the S&P 500 by 122.529%.
-
Which is a Better Dividend Stock SINT or XAIR?
SINTX Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SINTX Technologies pays -- of its earnings as a dividend. Beyond Air pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SINT or XAIR?
SINTX Technologies quarterly revenues are $367K, which are smaller than Beyond Air quarterly revenues of $798K. SINTX Technologies's net income of -$6.2M is higher than Beyond Air's net income of -$13.4M. Notably, SINTX Technologies's price-to-earnings ratio is -- while Beyond Air's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SINTX Technologies is 1.01x versus 7.31x for Beyond Air. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SINTSINTX Technologies1.01x -- $367K -$6.2M XAIRBeyond Air7.31x -- $798K -$13.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
